SPX3,998.84-72.86 -1.79%
DIA340.03-4.71 -1.37%
IXIC11,239.94-221.56 -1.93%

Barclays Maintains Overweight on Exscientia, Lowers Price Target to $12

Benzinga · 11/16/2022 06:47
Barclays analyst Peter Lawson maintains Exscientia (NASDAQ:EXAI) with a Overweight and lowers the price target from $40 to $12.